AU2003205974A1 - Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine - Google Patents

Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine

Info

Publication number
AU2003205974A1
AU2003205974A1 AU2003205974A AU2003205974A AU2003205974A1 AU 2003205974 A1 AU2003205974 A1 AU 2003205974A1 AU 2003205974 A AU2003205974 A AU 2003205974A AU 2003205974 A AU2003205974 A AU 2003205974A AU 2003205974 A1 AU2003205974 A1 AU 2003205974A1
Authority
AU
Australia
Prior art keywords
guaiphenesine
terbutaline
salbutamol
combination
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003205974A
Inventor
Erica Lynne Du Plessis
Anna Hatzoudis
Bradley Ryan Parsons
Michael Zwelikude Radebe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adcock Ingram Intellectual Property Pty Ltd
Original Assignee
Adcock Ingram Intellectual Property Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Intellectual Property Pty Ltd filed Critical Adcock Ingram Intellectual Property Pty Ltd
Publication of AU2003205974A1 publication Critical patent/AU2003205974A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003205974A 2002-02-13 2003-02-13 Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine Abandoned AU2003205974A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200201244 2002-02-13
ZA2002/1244 2002-02-13
PCT/IB2003/000475 WO2003068206A1 (en) 2002-02-13 2003-02-13 Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine

Publications (1)

Publication Number Publication Date
AU2003205974A1 true AU2003205974A1 (en) 2003-09-04

Family

ID=27735422

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003205974A Abandoned AU2003205974A1 (en) 2002-02-13 2003-02-13 Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine

Country Status (2)

Country Link
AU (1) AU2003205974A1 (en)
WO (1) WO2003068206A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2424185B (en) * 2005-03-16 2009-12-30 Atulkumar Sumanbhai Patel A cough mixture
MX2012002687A (en) * 2009-09-03 2012-05-29 Vanangamudi Sulur Subramaniam Oral liquid formulation comprising salbutamol and guaifenesin.
WO2014191414A1 (en) * 2013-05-28 2014-12-04 Sanovel Ilac Sanayi Ve Ticaret A.S. Syrup formulation of salbutamol
US9549907B1 (en) * 2015-11-13 2017-01-24 Sovereign Pharmaceuticals, Llc Immediate release oral guaifenesin solution

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
WO2003068206A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
IL173050A0 (en) Glucopyranosyl derivatives and pharmaceutical compositions containing the same
HK1078851A1 (en) 2-Indolinone-monoethanesulphonate and the use thereof in preparing a pharmaceutical composition
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL233352A0 (en) Rna molecules and pharmaceutical compositions containing the same and uses thereof
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
IL163117A (en) Indazole derivatives and pharmaceutical compositions containing the same
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
IL174479A (en) Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
AU2003272903A1 (en) Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
AU2003218359A1 (en) Polymer composition and dosage forms comprising the same
AU2003236076A1 (en) Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them
AU2003257780A1 (en) Pharmaceutical compositions containing polydatin or its salts and their application

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase